Jack Kelly has been a senior contributor for Forbes since 2018, covering topics in career development, job market trends and workplace dynamics. His articles often focus on practical advice for ...
Evercore ISI analyst Gavin Clark-Gartner downgraded Spero Therapeutics (SPRO – Research Report) to a Hold on December 20 and set a price target of $5.00. The company’s shares closed last ...
Spero's chief executive Ankit Mahadevia said that the company remains committed to tebipenem, despite its shift in focus to SPR720, an oral therapy for the treatment of a rare pulmonary disease ...
During the last three months, 4 analysts shared their evaluations of Spero Therapeutics SPRO, revealing diverse outlooks from bullish to bearish. The following table summarizes their recent ...
Jack Ma, the cofounder of Alibaba Group, made a rare public appearance on Sunday to give a speech about how AI will bring changes over the next two decades that "go beyond everyone's imagination ...
Jack Royston is Newsweek's Chief Royal Correspondent based in London, U.K. He reports on the British royal family—including King Charles III, Prince William, Kate Middleton, Prince Harry and ...